Date check: Today is Tuesday, July 28, 2026. The prompt labels the event as “tomorrow,” but July 28 is today. The available event calendar indicates Teradyne is expected to report after the U.S. market close on July 28; investors should confirm the associated conference-call time through Teradyne IR.
Teradyne enters 2Q26 earnings with fundamentals that remain exceptionally strong, but with a high bar around the durability and timing of AI-test demand. The headline Q2 setup is relatively straightforward: consensus is close to the midpoint of management’s guidance, so the market’s focus should be less on whether TER clears the quarter and more on:
Teradyne’s 1Q26 result established a very high starting point: revenue reached a record $1.282 billion, up 87% year over year, while non-GAAP EPS was $2.56. The company characterized roughly 70% of revenue as AI-related, illustrating both the scale of the opportunity and the rising importance of a comparatively concentrated set of very large customers and device programs.
The stock setup is more balanced than it was at the late-June peak. TER closed at $334.81 on July 27, still about 61% above its January 2 close, but roughly 31% below its June 30 closing high of $483.84. That pullback may reduce some near-term valuation pressure, but expectations for an AI-exposed ATE leader remain elevated. A merely in-line print accompanied by cautious second-half commentary could therefore still be insufficient.
| Metric | Management 2Q26 guide | Street expectation* | 1Q26 actual |
|---|---|---|---|
| Revenue | $1.15B–$1.25B | $1.21B | $1.282B |
| Non-GAAP EPS | $1.86–$2.15 | $2.05 | $2.56 |
| Gross margin | 58%–59% | 58.5% | 60.9% |
| Semiconductor Test revenue | — | $1.041B | $1.111B |
*Street estimates cited in the July 24 market digest.
Consensus revenue is about 5% above the low end of guidance and only 3% below the high end, while consensus EPS is modestly above the guidance midpoint. In other words, the market appears to expect a solid execution quarter—not a material guide-down—but it is not clearly underwriting a blowout result.
The expected sequential revenue decline from 1Q is not necessarily a demand warning. Management framed 1Q as benefiting from peak AI-driven volumes, favorable mix, and some nonrecurring operational benefits. The more consequential question is whether Q2 results and bookings support the company’s view that 2026 is a strong growth year despite pronounced quarterly lumpiness.
The structural argument for TER remains compelling:
The most bullish outcome would combine an above-guide Q2 with evidence that demand remains healthy across custom compute, merchant GPU, networking, HBM/DRAM, and AI-data-center power—rather than being driven by one or two concentrated programs.
The main risk is not that AI demand disappears; it is that test-equipment demand proves highly program-specific, acceptance-dependent, and uneven by quarter.
Management explicitly cautioned that:
This matters especially for the second half. Management said it expected 55%–60% of annual revenue in 1H26, a wide range that reflects both continued strong demand signals and uncertainty around large-customer ordering patterns and AI-data-center buildout timing. Investors will want a much sharper read on whether the company is trending toward the favorable end of that range and whether 2H demand is now becoming more visible.
A revenue and EPS beat should be expected to some degree given Teradyne’s recent ability to fulfill quick-turn demand and manage supply-chain execution. The more important question is where the upside comes from:
Semiconductor Test is the central earnings driver. In 1Q, the segment generated $1.111 billion of revenue, including approximately:
Investors should look for commentary on the mix within SoC—particularly custom AI ASICs, merchant compute/GPU, networking, automotive/industrial power for AI data centers, and mobile. A healthy memory result would be particularly helpful, because management had indicated HBM/DRAM momentum could be stronger in the back half.
Management guided Q2 gross margin to 58%–59%, down from 1Q’s record 60.9%. About half of the expected sequential decline was attributed to nonrecurring operational benefits in 1Q, with the remainder tied to product mix normalization.
Thus, a 58%-plus margin is not a negative by itself. The more important signals are:
This will likely determine the stock’s reaction. Management previously described:
A constructive earnings call would offer greater confidence that memory, networking, IST, Product Test, and Robotics can offset the expected moderation in first-half-weighted compute programs.
Management has line of sight to roughly $50 million of merchant-GPU revenue in 2026. That is not large relative to current consolidated revenue, but the strategic importance is much greater: successfully qualifying and ramping Teradyne’s platform at a merchant-GPU customer could unlock a multi-year share-gain path.
Key questions:
Photon100 and the company’s silicon-photonics positioning are important long-term differentiators. However, management has been clear that the market is early and that the split of investment among different test insertions remains uncertain.
For this quarter, investors should focus on:
Robotics has moved in the right direction, with four consecutive quarters of sequential growth through 1Q26. The business also underwent restructuring in 2025, so the market will look for proof that the improved trajectory is durable.
Constructive indicators would include continued e-commerce, electronics-manufacturing, and semiconductor demand; better conversion of the sales funnel; and further AI-data-center-related deployments. Still, it is prudent not to overstate its near-term impact: Robotics was only $91 million of 1Q revenue.
Teradyne closed the MultiLane Test Products joint venture and acquired TestInsight during April. Combined, the transactions used approximately $165 million of cash in 2Q and were financed through the credit revolver. Investors should watch for:
In 1Q, Teradyne had two specifying customers and one purchasing customer representing more than 10% of revenue. Concentration is a natural consequence of AI infrastructure spending, but it raises the importance of program timing and customer-specific commentary. Any discussion of an order deferral, acceptance delay, or supply-chain bottleneck at a major customer could move the shares disproportionately.
Teradyne remains one of the more direct ways to express AI infrastructure spending through semiconductor test, with additional long-duration options in memory, high-speed interconnect, silicon photonics, production-board test, and robotics. Its 1Q performance showed that the company can translate AI demand into powerful operating leverage.
But this is now a proof-of-duration quarter, not simply a proof-of-demand quarter. The central issue is whether Q2 results demonstrate that the AI-driven opportunity is evolving from a first-half surge into a more diversified and visible multi-quarter growth cycle. A strong beat paired with better 2H visibility could re-establish momentum; an in-line result with vague commentary on timing could leave the stock vulnerable despite still-strong secular fundamentals.